Markets

World Genetic Testing Markets, Purposes and Applied sciences Report 2021-2025 with COVID-19 Pandemic Impression Updates & Government and Guide Guides

Dublin, Jan. 19, 2022 (GLOBE NEWSWIRE) — The “World Genetic Testing Market Forecasts for Purposes and Applied sciences 2021-2025 – COVID-19 Pandemic Impression Updates with Government and Guide Guides” report has been added to ResearchAndMarkets.com’s providing.

This report forecasts the market measurement out to 2025. The report contains detailed breakouts for 14 nations and 5 areas.

Is genomic most cancers testing bouncing again? What has occurred to Direct to Shopper testing? Will all newborns obtain Entire Genomic Sequencing at delivery?

The function of genetics in well being and illness is simply now being understood. This new information, mixed with decrease pricing is driving the Genetic Testing business to report development. New medication might solely work for individuals with a sure genetic make-up, and this too is driving the Genetic Testing Trade. The normal genetic testing market is rising in quantity and rising within the breadth of assessments creating new life, and new issues for the business.

Predictive Diagnostics? Pharmacogenomic Testing? Direct to Shopper? Discover out concerning the expertise in readily understood phrases that specify the jargon. What are the problems? Discover the alternatives and the pitfalls. Perceive development expectations and the final word market forecasts for the subsequent 5 years.

Genetic Testing Latest Developments

  • Progenity Revenues Fall on COVID-19 Impact

  • Natera Launches Tumor Genomic Profiling Assay

  • 23andMe To Go Public

  • Guardant Well being to Provide Tumor Tissue Sequencing

  • Ancestry Quits Well being Providing

  • DTC Agency MyDNA Merges With Gene by Gene

  • Aetna Protection for NIPT to Embody All Pregnancies

  • Agios Prescribed drugs, PerkinElmer Accomplice on Hereditary Anemia Genetic Testing

  • Tumor, Germline Testing of Most cancers Sufferers Can Give Discordant Outcomes

  • Invitae Completes Acquisition of ArcherDx

  • Prenetics Receives $15M Funding

  • Sanford Well being Invests $800K in TruGenomix as A part of PTSD Take a look at Alliance

  • Preconception Service Screening Trial Begins in Australia

  • Genetic Testing Medical Use Simply Starting

  • Fulgent Genetics Q1 Revenues Soar 44 %

  • Blueprint Genetics, NICER Consortium Creating Genetic Take a look at for Immunologic, Hematologic Problems

  • Natera Terminates Qiagen Settlement for Creating NGS-Based mostly Genetic Exams

  • Invitae Acquires Three Firms: YouScript, Genelex, Diploid

  • PerkinElmer SCID Take a look at Chosen for New child Screening Analysis in England

  • Germline Most cancers Danger Mutations Typically Reported in Tumor Testing

  • Blueprint Genetics, Archimedlife to Launch Genetic Testing in North America

  • Invitae to Provide No-Cost Genetic Testing to Pancreatic Most cancers Sufferers

  • Phosphorus Affords DNA Testing to Assess Illness Danger

  • Arivale Shuts Down Personalised Wellness Enterprise

  • ArcherDX Acquires Child Genes

  • MDxHealth, LifeLabs Ink Distribution Settlement for Prostate Most cancers Assay

  • Thermo Fisher Purchases 9 % Stake in Yourgene Well being

  • Invitae Companions to Develop Free Epilepsy Genetic Testing Program

  • Illumina, Chinese language Agency Accomplice on NGS System for Genetic Illness Dx

  • NanoString Applied sciences Costs $103.5M Frequent Inventory Providing

  • Canine Shopper Genomics Agency Embark Veterinary Raises $10M

  • Yourgene Well being to Purchase Elucigene

  • Helix, AdventHealth Accomplice on Genetic Screening Examine

Market Developments

Elements Driving Progress

  • Genetic Discoveries Creating New Diagnostic Markets

  • Growing older Inhabitants a Boon for Diagnostics

  • Pharmacogenomics Drives Additional Progress.

  • Oncology and Liquid Biopsy Enter New Period

  • Fertility Apply Progress drives market

  • Direct to Shopper begins to interrupt out

Elements Limiting Progress

Instrumentation and Automation

Diagnostic Know-how Improvement

  • Subsequent Technology Sequencing Fuels a Revolution.

  • Impression of NGS on pricing

  • POCT/Self Testing Disruptive Drive

  • Pharmacogenomics Blurs Prognosis and Remedy

  • CGES Testing, A Courageous New World

  • Biochips/Big magneto resistance primarily based assay

Market Overview

Market Individuals Play Totally different Roles

  • Provider/pharmaceutical

  • Unbiased lab specialised/esoteric

  • Unbiased lab nationwide/regional

  • Unbiased lab analytical

  • Public Nationwide/regional lab

  • Hospital lab

  • Doctor lab

  • DTC Lab

  • Unbiased Genetic Testing Lab

  • Audit Physique

Genetic Exams -Varieties, Examples and Dialogue

  • Preimplantation Genetic Prognosis- An Rising Market

  • Prenatal Prognosis – New Applied sciences Create Alternative

  • New child Screening

  • Diagnostic Testing

  • Service Testing

  • Predictive and Presymptomatic Testing

  • Pharmacogenomics

  • Forensic Testing

  • Parental Testing

  • Ancestral Testing

Trade Construction

  • Hospital’s Testing Share

  • Economies of Scale

  • Hospital vs. Central Lab

  • Doctor Workplace Lab’s

  • Doctor’s and POCT

Profiles of Key Firms

  • 10. Genomics, Inc

  • 23andME Inc

  • Abbott Diagnostics

  • AccuraGen Inc.

  • Adaptive Biotechnologies

  • Admera Well being, LLC

  • Agena Bioscience, Inc

  • Agilent

  • Akonni Biosystems

  • Ancestry.com LLC

  • Anchor Dx

  • ArcherDx, Inc

  • ARUP Laboratories

  • Asuragen

  • Baylor Miraca Genetics Laboratories

  • Beckman Coulter, Inc.

  • Becton, Dickinson and Firm

  • BGI Genomics Co. Ltd

  • Bioarray Genetics

  • Biocept, Inc

  • Biodesix Inc

  • BioFluidica

  • BioGenex

  • Biolidics Ltd

  • bioMerieux Diagnostics

  • Bioneer Company

  • Bio-Rad Laboratories, Inc.

  • Bio-Techne

  • Most cancers Genetics

  • Caris Molecular Diagnostics

  • CellMax Life

  • Centogene

  • Chronix Biomedical

  • Circulogene

  • Medical Genomics

  • Shade Genomics

  • Full Genomics, Inc. – A BGI Firm

  • Cynvenio

  • Dante Labs

  • Datar Most cancers Genetics Restricted

  • Diasorin S.p.A

  • Epic Sciences

  • Epigenomics AG

  • Eurofins Scientific

  • Excellerate Bioscience

  • Exosome Diagnostics

  • Material Genomics

  • Fluidigm Corp

  • Basis Drugs

  • Freenome

  • FUJIFILM Wako Diagnostics

  • Fujirebio

  • GE World Analysis

  • GE Healthcare Life Sciences

  • Gene by Gene, Ltd.

  • Genedrive

  • GeneFirst Ltd.

  • Genetron Well being (Beijing) Co., Ltd.

  • Genewiz

  • Genomic Well being

  • Genomics England

  • Genomics Personalised Well being (GPH)

  • GenomOncology

  • Genzyme Company

  • Grail, Inc

  • Grifols

  • Guardant Well being

  • Guardiome

  • HeiScreen

  • Helix

  • Helomics

  • Hologic

  • Horizon Discovery

  • HTG Molecular Diagnostics

  • Human Longevity, Inc.

  • iCellate

  • Illumina

  • Incell Dx

  • Inivata

  • Built-in Diagnostics

  • Invitae Company

  • Invivoscribe

  • Karius

  • Macrogen

  • MDNA Life SCIENCES, Inc

  • MDx Well being

  • Medgenome

  • Meridian Bioscience

  • Mesa Biotech

  • MIODx

  • miR Scientific

  • MNG Labs

  • Molecular MD

  • NantHealth, Inc.

  • Natera

  • Nebula Genomics

  • NeoGenomics

  • New Oncology

  • Novogene Bioinformatics Know-how Co., Ltd.

  • Omega Bioservices

  • OncoDNA

  • ORIG3N, Inc.

  • Origene Applied sciences

  • Oxford Nanopore Applied sciences

  • Pacific Biosciences

  • Panagene

  • Perkin Elmer

  • Private Genome Diagnostics

  • Personalis

  • Precipio

  • PrecisionMed

  • Promega

  • Protagen Diagnostics

  • Qiagen Gmbh

  • Quantumdx

  • Regeneron

  • Roche Molecular Diagnostics

  • Roswell Biotechnologies

  • Seegene

  • Sequencing.com

  • Siemens Healthineers

  • simfo GmbH

  • Singlera Genomics Inc

  • SkylineDx

  • Stratos Genomics

  • Positive Genomics, Inc.

  • Sysmex

  • Sysmex Inostics

  • Tempus Labs, Inc

  • Thermo Fisher Scientific Inc

  • Veritas Genetics

  • Volition

For extra details about this report go to https://www.researchandmarkets.com/r/g2lf6j

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wooden, Senior Press Supervisor press@researchandmarkets.com For E.S.T Workplace Hours Name 1-917-300-0470 For U.S./CAN Toll Free Name 1-800-526-8630 For GMT Workplace Hours Name +353-1-416-8900

Related posts

Greenback edges up, foreign money markets sluggish forward of cbank conferences

admin

European markets look ahead to Fed assembly, Ukraine considerations

admin

Gold prices inch up, investors shift focus to upcoming US economic data

admin